All In Biotech

Drug Trial Radar · NCT05557409

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer's Disease Agitation

Last checked: Nov 19, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 408 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

408

Actual

Start

Sep 6, 2022

Primary completion

Nov 21, 2024

Study completion Dec 21, 2024

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 28, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 65 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial was a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.

Conditions

  • Agitation in Patients With Dementia of the Alzheimer's Type
  • Alzheimer Disease
  • Agitation

Interventions

  • AXS-05Drug

    AXS-05 tablets, taken twice daily

  • PlaceboDrug

    Placebo tablets, taken twice daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohen-Mansfield Agitation Inventory (CMAI)Time frame: Up to 5 weeks

Locations

55 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinical Research Site

    Peoria, Arizona

  • Clinical Research Site

    Tempe, Arizona

  • Clinical Research Site

    Tucson, Arizona

  • Clinical Research Site

    Canoga Park, California

  • Clinical Research Site

    Long Beach, California

  • Clinical Research Site

    Los Alamitos, California

  • Clinical Research Site

    Walnut Creek, California

  • Clinical Research Site

    West Covina, California

  • Clinical Research Site

    Bonita Springs, Florida

  • Clinical Research Site

    Brandon, Florida

  • Clinical Research Site

    Green Acres, Florida

  • Clinical Research Site

    Hialeah, Florida

  • Clinical Research Site

    Hollywood, Florida

  • Clinical Research Site

    Kissimmee, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    Miami Gardens, Florida

  • Clinical Research Site

    Miami Lakes, Florida

  • Clinical Research Site

    Orlando, Florida

  • Clinical Research Site

    Pembroke Pines, Florida

  • Clinical Research Site

    Tampa, Florida

  • Clinical Research Site

    Tampa, Florida

  • Clinical Research Site

    Augusta, Georgia

  • Clinical Research Site

    College Park, Georgia

  • Clinical Research Site

    Columbus, Georgia

  • Clinical Research Site

    Wichita, Kansas

  • Clinical Research Site

    Marrero, Louisiana

  • Clinical Research Site

    Braintree, Massachusetts

  • Clinical Research Site

    Flint, Michigan

  • Clinical Research Site

    Rochester Hills, Michigan

  • Clinical Research Site

    Troy, Michigan

  • Clinical Research Site

    Chesterfield, Missouri

  • Clinical Research Site

    Berlin, New Jersey

  • Clinical Research Site

    Toms River, New Jersey

  • Clinical Research Site

    Brooklyn, New York

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.